Hey there, health enthusiasts and pharma aficionados! Buckle up because we're about to dive into the exciting realm of Regeneron Pharmaceuticals. Get ready to hear all about their jaw-dropping preliminary results for the fourth quarter of 2021!
Picture this: Regeneron galloping into the new year with a dazzling report of Eylea's U.S. sales reaching a staggering $1.34 billion. Woah, talk about making it rain! It looks like this innovative pharmaceutical company is firing on all cylinders and leaving other contenders in the dust.
